Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The tremendous capacity of bone to regenerate is indicative of the presence of stem cells with the capability, by definition, to self-renew as well as to give rise to daughter cells. These primitive progenitors, termed mesenchymal stem cells or bone marrow stromal stem cells, exist postnatally, and are multipotent with the ability to generate cartilage, bone, muscle, tendon, ligament, and fat. Given the demographic challenge of an ageing population, the development of strategies to exploit the potential of stem cells to augment bone formation to replace or restore the function of traumatized, diseased, or degenerated bone is a major clinical and socioeconomic need. Owing to the developmental plasticity of mesenchymal stem cells, there is great interest in their application to replace damaged tissues. Combined with modern advances in gene therapy and tissue engineering, they have the potential to improve the quality of life for many. Critical in the development of this field will be an understanding of the phenotype, plasticity, and potentiality of these cells and the tempering of patients' expectations driven by commercial and media hype to match current laboratory and clinical observations.

Original publication

DOI

10.1385/scr:1:2:169

Type

Journal article

Journal

Stem cell reviews

Publication Date

01/2005

Volume

1

Pages

169 - 178

Addresses

Bone and Joint Research Group, University of Southampton, Southampton S016 6YD, UK. roco@soton.ac.uk

Keywords

Musculoskeletal System, Animals, Humans, Bone Neoplasms, Mesenchymal Stem Cell Transplantation, Tissue Engineering, Cell Differentiation, Cell Lineage, Mesenchymal Stromal Cells